Cargando…
Identification of a Thyroid Hormone Derivative as a Pleiotropic Agent for the Treatment of Alzheimer’s Disease
The identification of effective pharmacological tools for Alzheimer’s disease (AD) represents one of the main challenges for therapeutic discovery. Due to the variety of pathological processes associated with AD, a promising route for pharmacological intervention involves the development of new chem...
Autores principales: | Runfola, Massimiliano, Perni, Michele, Yang, Xiaoting, Marchese, Maria, Bacci, Andrea, Mero, Serena, Santorelli, Filippo M., Polini, Beatrice, Chiellini, Grazia, Giuliani, Daniela, Vilella, Antonietta, Bodria, Martina, Daini, Eleonora, Vandini, Eleonora, Rudge, Simon, Gul, Sheraz, Wakelam, Michale O. J., Vendruscolo, Michele, Rapposelli, Simona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704018/ https://www.ncbi.nlm.nih.gov/pubmed/34959730 http://dx.doi.org/10.3390/ph14121330 |
Ejemplares similares
-
Melanocortin receptor agonist NDP-α-MSH improves cognitive deficits and microgliosis but not amyloidosis in advanced stages of AD progression in 5XFAD and 3xTg mice
por: Daini, Eleonora, et al.
Publicado: (2023) -
Collecting data through high throughput in vitro early toxicity and off-target liability assays to rapidly identify limitations of novel thyromimetics
por: Runfola, Massimiliano, et al.
Publicado: (2020) -
Endogenous 3-Iodothyronamine (T1AM) and Synthetic Thyronamine-Like Analog SG-2 Act as Novel Pleiotropic Neuroprotective Agents through the Modulation of SIRT6
por: Bellusci, Lorenza, et al.
Publicado: (2020) -
New Multitarget Approaches in the War Against Glioblastoma: A Mini-Perspective
por: Sestito, Simona, et al.
Publicado: (2018) -
Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders
por: Saponaro, Federica, et al.
Publicado: (2020)